Lobbying firm

IGM BIOSCIENCES, INC.

Development of engineered IgM antibodies

Filings
14
Clients
1
Total income
—
Lobbyists
1
Years active
2021–2024

Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.

Income by year

Fees reported, $ thousands 2021 to 2024

Filings

14 filings, newest first.
Filing Client Income Expenses
4th Quarter - Termination (No Activity)
4th Quarter 2024, no activity
IGM BIOSCIENCES, INC. — income $10,000 expenses
3rd Quarter - Report
3rd Quarter 2024
IGM BIOSCIENCES, INC. — income $50,000 expenses
2nd Quarter - Report
2nd Quarter 2024
IGM BIOSCIENCES, INC. — income $80,000 expenses
1st Quarter - Report
1st Quarter 2024
IGM BIOSCIENCES, INC. — income $110,000 expenses
4th Quarter - Report
4th Quarter 2023
IGM BIOSCIENCES, INC. — income $240,000 expenses
3rd Quarter - Report
3rd Quarter 2023
IGM BIOSCIENCES, INC. — income $230,000 expenses
2nd Quarter - Report
2nd Quarter 2023
IGM BIOSCIENCES, INC. — income $230,000 expenses
1st Quarter - Report
1st Quarter 2023
IGM BIOSCIENCES, INC. — income $230,000 expenses
4th Quarter - Report
4th Quarter 2022
IGM BIOSCIENCES, INC. — income $210,000 expenses
3rd Quarter - Report
3rd Quarter 2022
IGM BIOSCIENCES, INC. — income $190,000 expenses

Clients

Everyone this filer has reported for, with the reports filed and the income they disclose.

ClientReportsIncome
IGM BIOSCIENCES, INC. 13 —

Lobbyists

Everyone named on this filer's reports, with the government post they most recently disclosed here.

LobbyistCovered position, as disclosed
ANDREW WESLEY WOMACK —

Affiliated organisations

OrganisationLocation
IGM AUTOIMMUNITY AND INFLAMMATION, INC. Mountain View, CA, US
IGM INFECTIOUS DISEASES, INC. Mountain View, CA, US

From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.